Task: Answer the multiple choice question.
Query: Which drug exhibits a 3.328% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: CCN(Cc1ccc2c(c1)OCO2)C(=O)CSc1nc(C)nc2sc(C)c(C)c12
b: O=C1CC(C(=O)Nc2ccccc2)N=C(N2CCOCC2)N1
c: Cc1cc(C)c(C)c(S(=O)(=O)N2CCN(Cc3nc4ccccc4[nH]3)CC2)c1C
Answer: b. O=C1CC(C(=O)Nc2ccccc2)N=C(N2CCOCC2)N1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1CC(C(=O)Nc2ccccc2)N=C(N2CCOCC2)N1
O=C1CC(C(=O)Nc2ccccc2)N=C(N2CCOCC2)N1
2-morpholin-4-yl-6-oxo-N-phenyl-4,5-dihydro-1H-pyrimidine-4-carboxamide